The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Macrophage Mitochondrial Oxidative Stress Promotes Atherosclerosis and Nuclear Factor-κB–Mediated Inflammation in Macrophages
Open accessAbstract
Rationale: Mitochondrial oxidative stress (mitoOS) has been shown to correlate with the progression of human atherosclerosis. However, definitive cell type–specific causation studies in vivo are lacking, and the molecular mechanisms of potential proatherogenic effects remain to be determined. Objective: Our aims were to assess the importance of macrophage mitoOS in atherogenesis and to explore the underlying molecular mechanisms. Methods and Results: We first validated Western diet–fed Ldlr −/− mice as a model of human mitoOS–atherosclerosis association by showing that non-nuclear oxidative DNA damage, a marker of mitoOS in lesional macrophages, correlates with aortic root lesion development. To investigate the importance of macrophage mitoOS, we used a genetic engineering strategy in which the OS suppressor catalase was ectopically expressed in mitochondria (mCAT) in macrophages. MitoOS in lesional macrophages was successfully suppressed in these mice, and this led to a significant reduction in aortic root lesional area. The mCAT lesions had less monocyte-derived cells, less Ly6c hi monocyte infiltration into lesions, and lower levels of monocyte chemotactic protein-1. The decrease in lesional monocyte chemotactic protein-1 was associated with the suppression of other markers of inflammation and with decreased phosphorylation of RelA (NF-κB p65), indicating decreased activation of the proinflammatory NF-κB pathway. Using models of mitoOS in cultured macrophages, we showed that mCAT suppressed monocyte chemotactic protein-1 expression by decreasing the activation of the IκB-kinase β–RelA NF-κB pathway. Conclusions: MitoOS in lesional macrophages amplifies atherosclerotic lesion development by promoting NF-κB–mediated entry of monocytes and other inflammatory processes. In view of the mitoOS–atherosclerosis link in human atheromata, these findings reveal a potentially new therapeutic target to prevent the progression of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Self-citationConditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis
VALAVANIDIS, A., VLACHOGIANNI, T., & FIOTAKIS, C. (2009) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590500902885684 · Cited by 1,978
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789 · cited 1×
“421 Oxidative phosphorylation in the mitochondria produces limited physiological levels of superoxide, with most being converted to hydrogen peroxide by superoxide dismutase.(1)”
BackgroundExtension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724
Self-citationSerbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,669
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
NF-κB activation by reactive oxygen species: Fifteen years later
Gloire, G., Legrand-Poels, S., & Piette, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,537
Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28549 · Cited by 1,323
Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., & Pittet, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29950 · Cited by 1,148
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Wu, L. L., Chiou, C.-C., Chang, P.-Y., & Wu, J. T. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.09.010 · Cited by 990
Bulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K.-Y., Sack, M. N., Kastner, D. L., & Siegel, R. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102049 · Cited by 860 · cited 2×
“ies suggesting that nonmitochondrial ROS can inhibit proinflammatory cytokine induction.(37,38) Thus, mitoOS has distinct”
BackgroundMitochondrial Dysfunction in Atherosclerosis
Madamanchi, N. R., & Runge, M. S. (2007) · Circulation Research · doi:10.1161/01.res.0000258450.44413.96 · Cited by 797
Chemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752
Kuziel, W. A., Morgan, S. J., Dawson, T. C., Griffin, S., Smithies, O., Ley, K., & Maeda, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12053 · Cited by 709
Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis
Drechsler, M., Megens, R. T. A., van Zandvoort, M., Weber, C., & Soehnlein, O. (2010) · Circulation · doi:10.1161/circulationaha.110.961714 · Cited by 698
Dai, D.-F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintrón, M., Chen, T., Marcinek, D. J., Dorn, G. W., Kang, Y. J., Prolla, T. A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.232306 · Cited by 527
Self-citationp47phox is required for atherosclerotic lesion progression in ApoE–/– mice
Barry-Lane, P. A., Patterson, C., van der Merwe, M., Hu, Z., Holland, S. M., Yeh, E. T. H., & Runge, M. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111927 · Cited by 489
Mitochondrial Integrity and Function in Atherogenesis
Ballinger, S. W., Patterson, C., Knight-Lozano, C. A., Burow, D. L., Conklin, C. A., Hu, Z., Reuf, J., Horaist, C., Lebovitz, R., Hunter, G. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000023921.93743.89 · Cited by 478
Oxidized Low-Density Lipoprotein and Atherosclerosis
Steinberg, D., & Witztum, J. L. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179697 · Cited by 460
Seimon, T. A., Nadolski, M. J., Liao, X., Magallon, J., Nguyen, M., Feric, N. T., Koschinsky, M. L., Harkewicz, R., Witztum, J. L., Tsimikas, S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.010 · Cited by 457
Self-citationDöring, Y., Manthey, H. D., Drechsler, M., Lievens, D., Megens, R. T. A., Soehnlein, O., Busch, M., Manca, M., Koenen, R. R., Pelisek, J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.046755 · Cited by 456
NF-κB RelA Phosphorylation Regulates RelA Acetylation
Chen, L.-F., Williams, S. A., Mu, Y., Nakano, H., Duerr, J. M., Buckbinder, L., & Greene, W. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.7966-7975.2005 · Cited by 438
Bergmark, C., Dewan, A., Orsoni, A., Merki, E., Miller, E. R., Shin, M.-J., Binder, C. J., Hörkkö, S., Krauss, R. M., Chapman, M. J., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800174-jlr200 · Cited by 407
Yang, F., Tang, E., Guan, K., & Wang, C.-Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5630 · Cited by 392
Myoishi, M., Hao, H., Minamino, T., Watanabe, K., Nishihira, K., Hatakeyama, K., Asada, Y., Okada, K.-I., Ishibashi-Ueda, H., Gabbiani, G., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.682054 · Cited by 370
van Gils, J. M., Derby, M. C., Fernandes, L. R., Ramkhelawon, B., Ray, T. D., Rayner, K. J., Parathath, S., Distel, E., Feig, J. L., Alvarez-Leite, J. I., et al. (2012) · Nature Immunology · doi:10.1038/ni.2205 · Cited by 365
Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease
Corral-Debrinski, M., Shoffner, J. M., Lott, M. T., & Wallace, D. C. (1992) · Mutation Research/DNAging · doi:10.1016/0921-8734(92)90021-g · Cited by 364
Trogan, E., Feig, J. E., Dogan, S., Rothblat, G. H., Angeli, V., Tacke, F., Randolph, G. J., & Fisher, E. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511043103 · Cited by 346
Kanters, E., Pasparakis, M., Gijbels, M. J. J., Vergouwe, M. N., Partouns-Hendriks, I., Fijneman, R. J. A., Clausen, B. E., Förster, I., Kockx, M. M., Rajewsky, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18580 · Cited by 340
The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells
Gargalovic, P. S., Gharavi, N. M., Clark, M. J., Pagnon, J., Yang, W.-P., He, A., Truong, A., Baruch-Oren, T., Berliner, J. A., Kirchgessner, T. G., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000242903.41158.a1 · Cited by 338
Potteaux, S., Gautier, E. L., Hutchison, S. B., van Rooijen, N., Rader, D. J., Thomas, M. J., Sorci-Thomas, M. G., & Randolph, G. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43802 · Cited by 334
Judkins, C. P., Diep, H., Broughton, B. R. S., Mast, A. E., Hooker, E. U., Miller, A. A., Selemidis, S., Dusting, G. J., Sobey, C. G., & Drummond, G. R. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00799.2009 · Cited by 299
Yu, E., Calvert, P. A., Mercer, J. R., Harrison, J., Baker, L., Figg, N. L., Kumar, S., Wang, J. C., Hurst, L. A., Obaid, D. R., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002271 · Cited by 283
Miller, Y. I., Viriyakosol, S., Worrall, D. S., Boullier, A., Butler, S., & Witztum, J. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000159891.73193.31 · Cited by 280
Huo, Y., Weber, C., Forlow, S. B., Sperandio, M., Thatte, J., Mack, M., Jung, S., Littman, D. R., & Ley, K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12877 · Cited by 266
Protective Role of Uncoupling Protein 2 in Atherosclerosis
Blanc, J., Alves-Guerra, M. C., Esposito, B., Rousset, S., Gourdy, P., Ricquier, D., Tedgui, A., Miroux, B., & Mallat, Z. (2003) · Circulation · doi:10.1161/01.cir.0000051722.66074.60 · Cited by 240
Mercer, J. R., Yu, E., Figg, N., Cheng, K.-K., Prime, T. A., Griffin, J. L., Masoodi, M., Vidal-Puig, A., Murphy, M. P., & Bennett, M. R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.026 · Cited by 188
Sung, F. L., Zhu, T. Y., Au-Yeung, K. K. W., Siow, Y. L., & Karmin, O. (2002) · Kidney International · doi:10.1111/j.1523-1755.2002.kid577.x · Cited by 181
Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs
Subramanian, M., Thorp, E., Hansson, G. K., & Tabas, I. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64617 · Cited by 164
Self-citationSeimon, T. A., Wang, Y., Han, S., Senokuchi, T., Schrijvers, D. M., Kuriakose, G., Tall, A. R., & Tabas, I. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37262 · Cited by 159
Self-citationZhang, H., Luo, Y., Zhang, W., He, Y., Dai, S., Zhang, R., Huang, Y., Bernatchez, P. N., Giordano, F. J., Shadel, G. S., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060960 · Cited by 157
High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo
Bursill, C. A., Castro, M. L., Beattie, D. T., Nakhla, S., van der Vorst, E. P. C., Heather, A. K., Barter, P. J., & Rye, K.-A. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.211342 · Cited by 153
Ma, Y., Wang, W., Zhang, J., Lu, Y., Wu, W., Yan, H., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035835 · Cited by 138
Self-citationPeroxiredoxin 2 Deficiency Exacerbates Atherosclerosis in Apolipoprotein E–Deficient Mice
Park, J., Yoo, J. Y., Jeong, S., Choi, J., Lee, M., Lee, M.-N., Lee, J. H., Kim, H. C., Jo, H., Yu, D., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.245530 · Cited by 133
MacRitchie, N. A., Grassia, G., Sabir, S. R., Maddaluno, M., Welsh, P. I., Sattar, N. A., Ialenti, A., Kurowska‐Stolarska, M., McInnes, I. B., Brewer, J. M., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251314 · Cited by 125
Suzuki, M., Tsujikawa, M., Itabe, H., Du, Z.-J., Xie, P., Matsumura, N., Fu, X., Zhang, R., Sonoda, K., Egashira, K., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.097683 · Cited by 123
Bylund, J., MacDonald, K. L., Brown, K. L., Mydel, P. M., Collins, L. V., Hancock, R. E. W., & Speert, D. P. (2007) · European Journal of Immunology · doi:10.1002/eji.200636651 · Cited by 117
Cook, A. D., Braine, E. L., & Hamilton, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4816 · Cited by 109
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice
Zamara, E., Galastri, S., Aleffi, S., Petrai, I., Aragno, M., Mastrocola, R., Novo, E., Bertolani, C., Milani, S., Vizzutti, F., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.007 · Cited by 103
IκBζ Is a Transcriptional Key Regulator of CCL2/MCP-1
Hildebrand, D. G., Alexander, E., Hörber, S., Lehle, S., Obermayer, K., Münck, N., Rothfuss, O. C., Frick, J.-S., Morimatsu, M., Schmitz, I., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300089 · Cited by 97
Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?
Williams, K. J., & Fisher, E. A. A. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200503000-00006 · Cited by 91
B cell subsets in atherosclerosis
Perry, H. M., Bender, T. P., & McNamara, C. A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00373 · Cited by 83
Gloire, G., Charlier, E., Rahmouni, S., Volanti, C., Chariot, A., Erneux, C., & Piette, J. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209542 · Cited by 63
Inhibition of NADPH Oxidase by Apocynin Attenuates Progression of Atherosclerosis
Kinkade, K. J., Streeter, J., & Miller, F. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140817017 · Cited by 63
Toll-like receptors in atherosclerosis
Tobias, P. S., & Curtiss, L. K. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351453 · Cited by 53
Myeloid IκBα Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques
Goossens, P., Vergouwe, M. N., Gijbels, M. J., Curfs, D. M. J., van Woezik, J. H. G., Hoeksema, M. A., Xanthoulea, S., Leenen, P. J. M., Rupec, R. A., Hofker, M. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022327 · Cited by 37
Madamanchi, N. R., Zhou, R.-H., Vendrov, A. E., Niu, X.-L., & Runge, M. S. (2010) · Circulation Research · doi:10.1161/circresaha.110.230904 · Cited by 18
Gusdon, A. M., Chen, J., Votyakova, T. V., & Mathews, C. E. (2009) · Methods in Enzymology · doi:10.1016/s0076-6879(08)04424-8 · Cited by 16
Cited by
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018) · Circulation Research · doi:10.1161/circresaha.117.311401 · Cited by 2,081
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Macrophage Phenotype and Function in Different Stages of Atherosclerosis
Tabas, I., & Bornfeldt, K. E. (2016) · Circulation Research · doi:10.1161/circresaha.115.306256 · Cited by 1,121
“This study demonstrated that fat-fed Ldlr mice have increased mitochondrial oxidative stress in lesional macrophages and that quelling mitochondrial oxidative stress in hematopoietic cells suppresses atherosclerosis and cytokine production by decreasing the activation of NF-κB.(71) Together, these studies demonstrate…”
Self-citationBrand, M. D. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.001 · Cited by 1,063
Recent insights into the cellular biology of atherosclerosis
Tabas, I., García-Cardeña, G., & Owens, G. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412052 · Cited by 1,016
Self-citation
Metadata
- Authors
- Wang, Y., Wang, G. Z., Rabinovitch, P. S., & Tabas, I.
- Venue
- Circulation Research
- Published
- 2014-01-31
- Volume
- 114
- Issue
- 3
- Pages
- 421-433
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2120047761
- Cited by
- 267
- References
- 61
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.